Quantification of Fibronectin 1 (FN1) splice variants, including two novel ones, and analysis of integrins as candidate FN1 receptors in bovine preimplantation embryos by Goossens, Karen et al.
BioMed CentralBMC Developmental Biology
ssOpen AcceResearch article
Quantification of Fibronectin 1 (FN1) splice variants, including two 
novel ones, and analysis of integrins as candidate FN1 receptors in 
bovine preimplantation embryos
Karen Goossens1, Ann Van Soom2, Alex Van Zeveren1, Herman Favoreel3 and 
Luc J Peelman*1
Address: 1Department of Nutrition, Genetics and Ethology, Faculty of Veterinary Medicine, Ghent University, Heidestraat 19, 9820 Merelbeke, 
Belgium, 2Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 
Merelbeke, Belgium and 3Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 
133, 9820 Merelbeke, Belgium
Email: Karen Goossens - Karen.Goossens@UGent.be; Ann Van Soom - Ann.Vansoom@UGent.be; Alex Van 
Zeveren - Alex.Vanzeveren@UGent.be; Herman Favoreel - Herman.Favoreel@UGent.be; Luc J Peelman* - Luc.Peelman@UGent.be
* Corresponding author    
Abstract
Background: Fibronectin 1 (FN1), a glycoprotein component of the extracellular matrix, exerts
different functions during reproductive processes such as fertilisation, gastrulation and
implantation. FN1 expression has been described to increase significantly from the morula towards
the early blastocyst stage, suggesting that FN1 may also be involved in early blastocyst formation.
By alternative splicing at 3 defined regions, different FN1 isoforms are generated, each with a
unique biological function. The analysis of the alternative FN1 splicing on the one hand and the
search for candidate FN1 receptors on the other hand during early bovine embryo development
may reveal more about its function during bovine preimplantation embryo development.
Results: RT-qPCR quantification of the FN1 splice isoforms in oocytes, embryos, cumulus cells and
adult tissue samples revealed a large variation in overall FN1 expression and in splice variant
expression. Moreover, two new FN1 transcript variants were identified, the first one expressed in
bovine preimplantation embryos and the second one expressed in cumulus cells.
In the search for candidate receptors for the new embryo specific FN1 isoform, RNA expression
analysis identified 5 α integrin subunits (ITGA2B, ITGA3, ITGA5, ITGA8, ITGAV) and 2 β integrin
subunits (ITGB1 and ITGB3) with a similar or overlapping RNA expression pattern as compared
to FN1. But double immunofluorescent stainings could not confirm complete co-localisation
between FN1 and one out of 3 selected integrins alpha subunits (ITGA3, ITGA5, ITGAV).
Conclusion: The existence of a new FN1 transcript variant, specifically expressed in morulae and
blastocysts strengthens the idea that FN1 is involved in the process of compaction and blastocyst
formation. Analysis of the integrin expression could not identify the binding partner for the embryo
specific FN1 transcript variant making further steps necessary for the identification of the FN1
receptor and the downstream effects of FN1-receptor binding.
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Fibronectin 1 (FN1) is a large adhesive glycoprotein of the
extracellular matrix composed of 2 nearly identical subu-
nits with a variety of binding domains for cell surface and
extracellular ligands. By means of these multiple interac-
tion sites, FN1 is involved in a variety of biological proc-
esses. Its major function is the support of cell adhesion,
but FN1 also plays a role in cytoskeleton organisation, cell
migration, many important physiological processes such
as wound healing, thrombosis and ageing [1-3], and in
diseases such as cancer, atherosclerosis and arthritis [4-7].
Structurally, FN1 is composed of 3 types of repeating
structural domains (type I, II and III domains – Figure 1)
and a single type III connecting segment (IIICS). This
organisation is conserved among species [8]. The func-
tional complexity of FN1 is carried out through its protein
diversity, which consists of multiple isoforms including
plasma FN1 [9] and cellular FN1 filaments [10]. Those
FN1 isoforms are the products of a single gene, and are
generated by alternative splicing at 3 sites (EIIIA, EIIIB and
IIICS) of the mRNA precursor [11]. Splicing at the EIIIA
and EIIIB regions happens by exon skipping, while the
IIICS region can be totally included, partially included or
totally excluded due to 3 alternative splice acceptor sites
and one alternative splice donor site within this exon [12].
In human and bovine, about 20 different protein encod-
ing mRNA transcripts are theoretically produced, but it is
still unknown whether all of these combinations do exist
in vivo [1,13]. The expression level of the spliced isoforms
and their relative proportion changes during embryonic
development and in pathological processes both spatially
and temporarily [14-18]. Each alternatively spliced
domain has unique biological functions and a lot of stud-
ies have been done to reveal the functions of each domain
and the splicing regulation mechanisms [13,19-22]. The
EIIIA and EIIIB regions are absent in plasma FN1 and
EIIIA/EIIIB containing FN1 is poorly expressed in normal
adult tissue but overexpressed in developing embryos,
wound healing and tumours [12,23].
Integrins are heterodimeric cell surface glycoprotein
receptors composed of 2 non-covalently associated subu-
nits α and β, linking the extracellular matrix (ECM) with
the intracellular cytoskeleton. Integrins mediate cell-cell
and cell-matrix adhesions and the dimerisation of specific
α with specific β subunits determines the specificity for the
ligand as well as intracellular signalling events [24]. Upon
binding of a ligand, e.g. FN1, integrins transduce signals
into the cell interior (outside-in signalling), but they can
also receive intracellular signals that regulate their ligand-
binding affinity (inside-out signalling) [25]. At least 10
different integrins can serve as FN1 receptors. Some are
specifically binding FN1 but others have multiple ligands
[26].
FN1 and its receptors have different functions in mamma-
lian reproduction and embryogenesis (sperm-oocyte
interactions, implantation, and placentation) [26-30] and
both the FN1 alternative splicing as well as the expression
of the integrin receptors are developmentally regulated.
So far, most studies have focussed on implantation and
placentation, but bovine embryos are special in the way
that they have a delayed implantation. In contrast to
human, the bovine blastocyst elongates in the uterine
lumen for several days, until attachment starts around day
Alternative splicing of the bovine FN1 geneFigure 1
Alternative splicing of the bovine FN1 gene. (A) Sche-
matic diagram of the domain structure of FN1, consisting of 
three repeating units, types I (red), II (green) and III (blue). 
Splicing can occur at two different type III repeats (EIIIB and 
EIIIA, dark blue) or at several locations within the IIICS 
region (yellow). (B) Positions of the primers for detection of 
the EIIIB splice variant. (C) Positions of the primers for 
detection of the EIIIA splice variant. (D) Positions of the 
primers for detection of the IIICS- and IIICS full length splice 
variant. Primers surrounding the alternative spliced regions 
(marked in red) enable the distinction between the long and 
short splice isoforms. The primers marked in green were 
used for specific amplification of the full-length isoforms and 
the boundary spanning primers, marked in yellow, were used 
for specific amplification of the short isoforms.
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significant rise in bovine FN1 expression was already
observed at time of transition from morula to blastocyst,
more than 10 days before bovine implantation occurs.
Moreover a significantly higher FN1 RNA expression was
found in bovine in vivo golden standard blastocysts, com-
pared to in vitro produced ones [33,34]. Until now, little
is known about the importance of the FN1 matrix during
compaction and early blastocyst formation. Takahashi et
al. [32] described that trophectodermal cells of bovine
hatched blastocyst have already acquired the ability to
adhere and outgrow on FN1. But, since at this stage of
development no attachment of the bovine blastocyst to
the uterine epithelium is occurring, other functions for
FN1 may be assumed. Moreover, a study about FN1
fibrillogenesis in Xenopus [35] suggested that the
dynamic assembly of the FN1 matrix is cell-type depend-
ent and a key event in regulating cell adhesion, migration
and differentiation. Based on these data we set up the
hypothesis that the embryonic FN1 matrix, formed at the
onset of blastocyst formation, may have the adhesive
property to link cells together and to provide a substrate
for cell layer migration.
In a first step to investigate this hypothesis, and to find a
link between the embryo culture conditions and altera-
tions in FN1 expression, RT-qPCR was performed for the
quantitative analysis of the FN1 splice variants in bovine
oocytes, pre-implantation embryos, cumulus cells and a
selection of adult tissues, followed by RT-qPCR and
immunofluorescent staining for the determination of
integrins as candidate FN1 receptors in bovine preimplan-
tation embryos.
Results
Quantitative expression analysis of the bovine FN1 splice 
variants
Primer validation experiment
For each alternatively spliced FN1 region (EIIIB, EIIIA and
IIICS), primer pairs were designed for specific amplifica-
tion of both splice variants. The positions of the primers
are displayed in Figure 1. Specific amplification was veri-
fied by agarose gel electrophoresis showing specific frag-
ments of the expected sizes (Table 1), by melt curve
analysis and by sequencing of the amplicons.
For the quantification of the amount of expression of each
splice isoform, different standard curves were generated
using specific PCR fragments obtained from plasmid con-
structs containing the specific splice variants as explained
in the section Methods. After determination of the mass
concentration, equimolar concentrations of the PCR
products were used for the generation of ten-fold serial
dilution series.
PCR efficiencies ranged from 88 to 100% and the accuracy
of the standard curves was evaluated by analysing each
standard dilution point as an unknown sample [36,37].
Results of the qPCR amplification of each splice variant in
the presence of excess of the alternative splice variant gave
equal CT values and quantities for each dilution point
demonstrating the specificity of the primer pairs for each
splice isoform (Additional file 1). The repeatability of the
assay was good, with a standard deviation of less than 0.5
CT between technical replicates. The accuracy of the
standard curves was evaluated by analysing each standard
dilution point as an unknown sample [36,37]. The coeffi-
cients of variation were less than 1% for the CT values and
ranged between 2 and 15% for the calculated quantities.
Quantification of alternative transcripts using boundary spanning 
primers
In a first step, conventional RT-PCR with primers sur-
rounding the alternatively spliced regions (Figure 1 –
Table 1; Primers 1–3) were used to get an indication of the
presence or absence of each splice isoform in bovine
oocytes, embryos, cumulus cells and adult tissues. The
results (Figure 2) demonstrated that the EIIIB region was
nearly absent in bovine oocytes and embryos whereas the
EIIIA region and the full-length IIICS region were highly
present. Cumulus cells on the other hand, had a different
expression pattern with lower expression of the EIIIB
region and near absence of the EIIIA and IIICS regions. In
adult tissue samples, the EIIIA and EIIIB regions were
mostly absent and the presence of multiple IIICS frag-
ments, suggest the expression of more than one transcript
isoform. The two main IIICS isoforms were the IIICS null
and the IIICS full-length isoforms while the intermediate
IIICS forms were hardly expressed in the analysed sam-
ples.
In the second experiment, RT-qPCR with specific primers
pairs was used for quantitative expression analysis of the
splice isoforms in the samples (Figure 3).
The overall FN1 expression was very low in bovine
oocytes and early embryonic stages and increased from
the morula stage onwards, followed by a spectacular rise
at the blastocyst stage (Additional file 2 for the statistical
analysis). The FN1 RNA expression was variable in the
adult tissue samples with very low FN1 RNA expression in
udder, spleen, muscle and heart tissue, moderate expres-
sion in kidney, uterus and ovaries and high FN1 RNA
expression in liver, lung, placenta and skin tissues.
The EIIIB+ isoform was absent or very low expressed in
most tissue samples, except in the uterus and cumulus
cells in which the EIIIB+ splice variant was predominantly
expressed. During embryo development, there was a shiftPage 3 of 16
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BMC Developmental Biology 2009, 9:1 http://www.biomedcentral.com/1471-213X/9/1in the EIIIB splice isoform expression from the EIIIB- var-
iant to the EIIIB+ variant around the hatched blastocyst
stage.
The EIIIA+ isoform was the main variant in all embryonic
stages. In cumulus cells and most tissue samples on the
other hand, the EIIIA- variant was mainly expressed. In the
reproductive tissues – placenta, uterus and ovary – the
EIIIA+ variant had a higher RNA expression level com-
pared to the other tissue samples.
The IIICS full length splice isoform was the only IIICS var-
iant expressed during bovine preimplantation embryo
development. In cumulus cells the IIIICS null isoform was
virtually the only IIICS variant, whereas in most tissue
samples both the null and full-length isoforms were
expressed.
Table 1: Primer and amplicon information
Primer Target Sequence Amplicon size (bp) Ta
(°C)
BtauFN1
primer pair 1
EIIIB region
Standard curve
5'-CAGAGACGGGCAAGAGAGAG-3'
5'-CAGGTTGGTGAGGGTGATG-3'
+ 1060
- 787
62
BtauFN1
primer pair 2
EIIIA region
Standard curve
5'-GCCCGTTTCCATCAATTACC-3'
5'-TGAGCCGGTCTGCTTGTC-3'
+ 819
- 549
62
BtauFN1
primer pair 3
IIICS region
Standard curve
5'-GCCCTCAAGAACAATCAGAAG-3'
5'-TGAAATGACCACTGCCAAAG-3'
+ 808
- 448
62
BtauFN1
primer pair 4
EIIIB region
Full-length region
5'-CATGCCGATCAGAGTTCCT-3'
5'-AAGAGTTTAGCGGGGTCCA-3'
202 62
BtauFN1
primer pair 5
EIIIA region
Full-length region
5'-GGACCATCGAAAACGAAAAC-3'
5'-GGAATCGACATCCACATCAG-3'
195 62
BtauFN1
primer pair 6
IIICS region
Full-length region
5'-AGGGGAGACGTAGACCATCA-3'
5'-GGCACTAGCAGAGGTTCCAG-3'
201 62
BtauFN1
primer pair 7
EIIIB region
Boundary spanning
5'-CATGCCGATCAGAGTTCCTG-3'
5'-GAGGGACAGCTGGGATGATG-3'
130 62
BtauFN1
primer pair 8
EIIIA region
Boundary spanning
5'-GGTAACCACCATTCCTGCAC-3'
5'-CCTGATACAACCACGGATGA-3'
189 62
BtauFN1
primer pair 9
IIICS region
Boundary spanning
5'-GGAGGAAAAAGACAGGCCAAG-3'
5'-GGCACTAGCAGAGGTTCCAG-3'
151 62
BtauFN1
primer pair 10
Conserved region
XM_864390
5'-ACTGCCCACTCCTACAACCA-3'
5'-TCTGCGAACACCACTCCA-3'
196 62
BtauITGA2B Integrin αIIb
NM_001014929
5'-TGGAAACACCCACGTCCA-3'
5'-CCAGCTTCTCCACGCTCAC-3'
155 60
BtauITGA3 Integrin α3
NM_001101900
5'-GGCAGACCTGAACAATGATG-3'
5'-CAATGCTTGCCACAGAGAAG-3'
191 61
BtauITGA4 Integrin α4
NM_174748
5'-AGACGAGGATCTCAACATCACA-3'
5'-AATGAGGCTGGACTTACAAACC-3'
147 60
BtauITGA5 Integrin α5
XM_614854
5'-GTGTGAGGCCGTGTATGAAG-3'
5'-CAGACCGAGGAGCAGGAG-3'
178 60
BtauITGA8 Integrin α8
XR_027842
5'-GCTCAAGTAGAAATAAGAGGAGT
GTC-3' 5'-AGGAGGGTGTCGCTGATG-3'
167 60
BtauITGA9 Integrin α9
XM_610637
5'-ATGTGACGGGAGAGGAGGAG-3'
5'-CGAGGTTGGAGATGGAGATG-3'
243 61
BtauITGA11 Integrin α11
XM_602058
5'-CGCCAGATCACGTTTGAGA-3'
5'-ACTCCAGCACTTTGGGTGTG-3'
190 60
BtauITGAD Integrin αD
NM_001102496
5'-GACTGCTCCATCGCTGACT-3'
5'-CACGACCAATGTCTTCTTCTG-3'
141 60
BtauITGAV Integrin αV
NM_174367
5'-GGGACTTCCAGACCATCAAG-3'
5'-GTCTATATCCGTGGCTCCTTTC-3'
275 61
BtauITGB1 Integrin β1
NM_174368
5'-TGAGGTGAACAGCGAAGACA-3'
5'-TTGCACTCACACACTCGACA-3'
231 60
BtauITGB2 Integrin β2
NM_175781
5'-GGCAGAAAGCAACATCCAG-3'
5'-TGATAAGCTCCACCACGTTC-3'
137 60
BtauITGB3 Integrin β3
XM_616376
5'-TTCTCCACCAGAGGCTATCA-3'
5'-TCTGCTTCTTCACCTCCTCA-3'
131 61
BtauITGB6 Integrin β6
NM_174698
5'-ACAACGGCAATGGTTCCTTC-3'
5'-GCTCCTGCACACGCACTC-3'
299 60
BtauITGB7 Integrin β7
NM_001105365
5'-CTACAGTCGCAGCCCAGAG-3'
5'-CCGGAGGGAGAAGAGAGTG-3'
260 60Page 4 of 16
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BMC Developmental Biology 2009, 9:1 http://www.biomedcentral.com/1471-213X/9/1Comparison of the FN1 expression between in vivo and in
vitro produced blastocysts by RT-qPCR (Figure 4) showed
a 2.5 fold higher FN1 RNA expression in in vivo compared
to in vitro produced blastocysts (P < 0.05). The splice var-
iant ratios did not differ between the two groups for the
EIIIB and the IIICS region (P > 0.05), and only a slight
increase in EIIIA- splice variant expression was observed
in in vivo blastocysts but this difference was not significant
(P > 0.05).
When the information of the 3 regions was taken together,
sequenced and compared to the 5 in silico predicted
bovine FN1 splice variants in the NCBI Entrez Gene data-
base [38] none of the described bovine splice variants
agreed with the bovine embryo specific variant (EIIIB-,
EIIIA+ and full-length IIICS). The embryo specific tran-
script variant, (in this paper nominated as FN1-ESV –
Genbank Accession Number: FJ513187), expressed in
both in vivo and in vitro preimplantation embryos, was
similar to the in silico predicted transcript variant 12
(Accession Number: XM_874147) but had a 75 bp longer
IIICS domain (amino acid sequence GHVPRGDVDHH-
LYPHVVGLNPNAST).
The combination of the mainly expressed subunits in
cumulus cells (EIIIB+, EIIIA-, IIICS-) also yielded a new
FN1 splice isoform, temporarily nominated as FN1-CSV
(Genbank Accession Number: FJ513188). In tissue sam-
ples, the expression pattern was more diverse and in most
of the cases a mixture of more than one transcript variant
was expressed but the main transcript variant in bovine
tissues agreed with the in silico predicted FN1 transcript
variant 10 (Accession Number: XM_873966).
Expression analysis of integrins as candidate FN1 receptors 
during bovine preimplantation embryo development
RNA expression analysis
Based on a literature search [24,25,27] primers were
designed for 9 integrin α and 5 integrin β subunits
described to act as receptors for FN1 (Table 1).
RT-qPCR analysis (Table 2 – Additional file 3) for those
14 integrins revealed that the RNA expression pattern of 6
subunits – ITGA2B, ITGA3, ITGA5, ITGA8, ITGAV and
ITGB3 – followed largely the overall FN1 RNA expression
during bovine preimplantation embryo development,
whereas ITGA4, ITGA9 and ITGA11 were expressed in
oocytes, 2-cell and 8-cell embryos but were absent in
morulae and blastocysts. ITGB1 was continuously
expressed during preimplantation embryo development.
ITGB2 and ITGB6 on the other hand, were absent in
bovine embryos and ITGAD and ITGB7 were only
expressed at the hatched blastocyst stage.
For the 6 integrin subunits that followed the FN1 RNA
expression pattern (ITGA2B, ITGA3, ITGA5, ITGA8,
ITGAV and ITGB3) RT-qPCR analyses were run on both in
vitro and in vivo embryo samples (2-cell, 8-cell and blasto-
cyst). The results (Figure 5) showed significant differences
in RNA expression between in vivo and in vitro produced
embryos for 4 of the tested integrins. ITGA2B (P = 0.0262)
and ITGA8 (P = 0.0147) were significantly higher
expressed in in vitro produced blastocyst, whereas the
opposite was the case for ITGA3 (P = 0.0461) and ITGB3
(P = 0.0238). The expression of ITGB3 was not only
increased at the blastocyst stage, but ITGB3 also showed a
significantly higher expression in 8-cell in vivo embryos.
The differences in RNA expression for ITGA5 and ITGAV
were not significant (P > 0.05).
Protein expression analysis
Double immunofluorescent stainings were performed for
FN1 in combination with one of the 3 integrins for which
suitable antibodies were commercially available, (ITGA3,
ITGA5 and ITGAV) on bovine in vitro produced embryos
of different developmental stages (2-cell, 8-cell, morula
and blastocyst; the results are not shown except for blast-
ocysts).
Results of the RT-PCR on oocytes, embryos, cumulus cells and tissue samplesFig re 2
Results of the RT-PCR on oocytes, embryos, cumulus 
cells and tissue samples. The RT-PCR reactions were 
performed with primer pairs 1–3, surrounding the alterna-
tively spliced regions and yielded PCR fragments of different 
lengths depending on the presence or absence of the alterna-
tively splice region, and were compared to the expression of 
the control gene GAPD. MM: molecular marker, Oo: oocyte, 
2C: in vitro 2-cell embryo, 8C: in vitro 8-cell embryo, M: in vitro 
morula, Bv: in vivo blastocyst, Bt: in vitro blastocyst, HB: in vitro 
hatched blastocyst, Cum: cumulus cells, K: kidney, Li: liver, 
Lu: Lung, Ud: udder, P: placenta, Sp: spleen, M: muscle, H: 
heart, Ut: uterus, Sk: skin, Ov: ovary.
MM  Oo   2C   8C   M   Bv   Bt  HB Cum K   Li   Lu  Ud   P  Sp   M   H   Ut  Sk  Ov
EIIIB Splice variant
EIIIA Splice variant
IIICS Splice variant
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Results of the quantitative expression analysis of the bovine FN1 splice variantsFig re 3
Results of the quantitative expression analysis of the bovine FN1 splice variants. The total FN1 RNA expression 
and the relative composition of each splice isoform was determined for the 3 alternatively spliced regions (A: EIIIB, B: EIIIA, C: 
IIICS). Oo: oocyte, 2C: in vitro 2-cell embryo, 8C: in vitro 8-cell embryo, M: in vitro morula, B: in vitro blastocyst, HB: in vitro 
hatched blastocyst, Cum: cumulus cells, K: kidney, Li: liver, Lu: Lung, Ud: udder, P: placenta, Sp: spleen, M: muscle, H: heart, Ut: 
uterus, Sk: skin, Ov: ovary. For each sample type, a t-test was performed to compared the relative expression of each splice 
isoform (* = P < 0.05; ** = P < 0.01).
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Comparison of the FN1 isoform expression in in vitro versus in vivo produced bovine blastocystsFigure 4
Comparison of the FN1 isoform expression in in vitro versus in vivo produced bovine blastocysts.
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BMC Developmental Biology 2009, 9:1 http://www.biomedcentral.com/1471-213X/9/1Bovine morulae and blastocysts were strongly positive for
FN1, ITGA3, ITGA5 and ITGAV. FN1 was mainly
expressed in the inner cell mass (ICM) of the blastocysts
but a filamentous network of FN1 fibrils was also
observed from the ICM towards the trophectodermal cells
(TE) (Figure 6A', B' and 6C'). The integrin subunit ITGA3
was predominantly detected at the cell membranes of the
TE whereas ITGA5 and ITGAV were both found mainly in
the ICM and less in the TE (Figure 6A, B and 6C). Yellow
spots on the merged images (Figure 6A", B" and 6C")
showed a partial co-localization of FN1 with ITGA5 and
ITGAV in the ICM and a partial co-localization between
FN1 and ITGA3 in the TE.
In order to study the FN1-integrin interaction in more
detail, higher magnification images (4.5× magnification;
Figure 6A"', B"' and 6C"') were analysed and confirmed
few yellow merged dots for FN1/ITGA5 and FN1/ITGAV
double immunofluorescent stainings, indicating a slight
co-localization between FN1 and those integrin subunits.
However, neither for ITGA5, nor for ITGAV full colocali-
zation with FN1 was observed.
In the TE cells, FN1 appeared as a filamentous network of
fibers in close apposition to the ITGA3 positive cell mem-
branes but true co-localization between ITGA3 and FN1
could not be observed.
Discussion
In this study, the analysis of FN1 splice variants and
integrins as candidate FN1 receptors was performed in
order to test our hypothesis that bovine embryonic FN1
expressed at the morula and early blastocyst stage, may be
involved in the adhesion and migration of embryonic cell
layers at the onset of differentiation.
The first objective of this study was to determine the FN1
splice isoforms expressed during bovine preimplantation
embryo development and to compare them with the ones
expressed in oocytes, cumulus cells and adult tissue sam-
ples. The optimized RT-qPCR assay revealed large differ-
ences in overall FN1 RNA expression and, more
importantly, large differences in splice variant expression.
The maternal FN1 transcript isoform, expressed in oocytes
and gradually degrading in 2-cell embryos, was identical
to the embryonic FN1 transcript isoform expressed from
the morula stage onwards. Sequencing followed by the
comparison of this splice variant (EIIIB-/EIIIA+/IIICS+)
with the in silico predicted bovine FN1 transcript variants
in the NCBI Entrez Gene database [38] revealed that it
constitutes a new FN1 splice isoform (Genbank Accession
Number: FJ513187) supporting our hypothesis that FN1
exerts a specific function during compaction and early
blastocyst formation.
Previous studies [33,34] reported that in vitro produced
embryos had a reduced FN1 RNA expression compared to
in vivo "golden standard" embryos. In vitro culture condi-
tions are largely different from the in vivo environment in
the maternal tract and deficiency in survival factors such
as cytokines and growth factors are known to have conse-
quences for the quality of the in vitro embryo by induction
of changes in gene expression, metabolism and even epi-
genetic modifications. As growth factors, cytokines, hor-
mones and even stress are also reported to act as
Table 2: Overview of the integrin RNA expression, relatively compared to the FN1 RNA expression, in bovine oocytes and 
preimplantation embryos
Gene Oocyte 2-cell 8-cell Morula Blastocyst Hatched Blastocyst
FN1 + - - + +++ +++
ITGA2B + - - - + +++
ITGA3 + + - - + +++
ITGA5 + - - + +++ +++
ITGA8 - - - - +/- ++
ITGAV + +/- - + +++ +++
ITGB3 + - +/- ++ +++ ++
ITGA4 + + + - - -
ITGA9 + + + - - -
ITGA11 + +/- +/- - - -
ITGAD - - - - - +
ITGB1 +++ +++ ++ + + +
ITGB2 - - - - - -
ITGB6 - - - - - -
ITGB7 - - - - - +
The integrins that follow the FN1 RNA expression pattern (marked in bold) are considered as candidate receptors for the FN1-ESV isoform (-: no 
expression, +/-: expression in part of the samples; + low expression; ++ moderate expression, +++ high expression compared to FN1 blastocyst 
expression).Page 8 of 16
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the FN1 splice variant expression between in vivo and in
vitro blastocysts was performed. The significantly higher
FN1 RNA expression found in in vivo blastocysts was not
associated with a switch in splice variant composition.
The FN1-ESV splice variant was also found in in vivo blas-
tocysts and the ratios between the splice variants
remained largely constant.
From the hatched blastocyst stage onwards, the expression
of the EIIIB region increased, pointing to a shift in FN1
splice variant expression from the FN1-ESV isoform
Integrin RNA expressionFigu e 5
Integrin RNA expression. Mean relative mRNA abundance of 6 integrins at 3 different time-points during bovine preimplan-
tation embryo development (2-cell, 8-cell and blastocyst) of in vitro (green) and in vivo (yellow) produced bovine embryos, 
determined by RT-qPCR. A t-test was performed and non-overlapping error bars indicate a significant difference between the 
according means (* = P < 0.05).
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Number: XM_864390). This shift goes together with the
onset of initial differentiation of the primitive endoderm
or hypoblast in cattle [42] and is not surprising since the
primitive endoderm was demonstrated to be the major
source of FN1 production [43]. The FN1 isoform 2
(EIIIA+/EIIIB+/IIICS+) is involved in cell lineage and tis-
sue rearrangements [17], processes that occur extensively
during early embryogenesis. The expression of a second
FN1 transcript variant in hatched blastocysts supports our
hypothesis that FN1 exerts multiple functions during blas-
tocyst formation.
Another remarkable finding was the difference in FN1 iso-
form expression between the oocyte (and early embryos)
and the surrounding cumulus cells. The cumulus cells
express another new FN1 isoform, named FN1-CSV (Gen-
bank Accession Number: FJ513188). The adhesion of
spermatozoa to the oolemma is mediated by integrins rec-
ognizing the RGD sequence in glycoproteins such as FN1
and vitronectin [44]. But since a different FN1 isoform is
expressed in oocytes and cumulus cells, a different func-
tion for FN1 can be expected.
In adult tissues, a variety of different splice variants was
found. In general, the EIIIB and EIIIA region were
Localisations of the FN1 and integrin subunits by double immunofluorescent staining on in vitro produced blastocystFigure 6
Localisations of the FN1 and integrin subunits by double immunofluorescent staining on in vitro produced blas-
tocyst. (A) Double immunofluorescent staining for ITGA3 (A, FITC), FN1 (A', Cy5) and merged signals (A"). ITGA3 was 
mainly expressed at the cell membranes of the TE cells. FN1 and ITGA3 were expressed adjacent to each other but no co-
localisation was found (A"'). (B) Double immunofluorescent staining for ITGA5 (B, FITC) and FN1 (B', Cy5) and merged signals 
(B"). (C) Double immunofluorescent staining for ITGAV (C, FITC) and FN1 (C', Cy5) and merged signals (C"). ITGA5 and 
ITGAV were mainly expressed in the ICM. Partial co-localisation with FN1 was observed for ITGA5 (B"') as well as ITGAV 
(C"') by the appearance of yellow areas when signals were merged (indicated by arrows) (Original Magnification ×400).
A $¶ $¶¶ $¶¶¶
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of these regions in normal adult tissues [16,45] but inclu-
sion during pathological conditions [4-7]. Soluble plasma
FN1 (EIIIB-/EIIIA-/IIICS-) [46] is particularly secreted by
hepatocytes, probably explaining the higher expression of
the IIICS- variant in liver tissue. It was not the main focus
of our research to study the FN1 isoform expression in
adult tissue samples, but the aberrant splice variant pat-
tern (EIIIB+/EIIIA+) in the reproductive tissues (placenta,
uterus and ovary) was remarkable, although not entirely
unexpected. These tissues are very proliferative and active,
and the inclusion of EIIIA and EIIIB occur under such con-
ditions [20,21,24]. Embryo implantation and placenta
formation require, besides cell migration, trophoblast dif-
ferentiation and villous mesenchyme formation, also
intensive vascular proliferation and angiogenesis [47-49],
explaining the higher inclusion of the EIIIA and EIIIB
regions.
Taking a closer look at the FN1-ESV isoform, it was seen
that the main difference with the most closely related iso-
form (in silico predicted isoform 12) was the inclusion of
a 75 bp fragment containing a second RGD motif, a TYR
fosforylation site and an ASN glycosylation site. The RGD
motif is the recognition site for interaction with integrins
and the conserved RGD motif is located in the 10th type III
domain, next to the PHSRN synergy site located in the 9th
type III domain. Upon interaction with the RGD ligand,
the integrins can transduce signals into the cell interior,
but they may also receive intracellular signals regulating
their cell binding affinity [50]. The various α integrin sub-
units have different cytoplasmic tails by which they are
able to activate different cellular responses upon binding
to a common extracellular ligand [28]. By the binding of
cytoskeleton linkage proteins such as talin, vinculin and
α-actinin to their cytoplasmic tail, integrins serve as trans-
membrane links between extracellular contacts and the
cytoskeleton [25] and act as modulators of cytoskeleton
organisation, an important process during blastocyst for-
mation. As the FN1-ESV isoform contains a second RGD
motif, the study of the integrin expression in bovine
embryos may help to find out more about the functions
of FN1 during blastocyst formation. ITGA5B1 and
ITGAVB3 are classical receptors for FN1 but at least 8
other different integrins may serve as receptors for
fibronectin and many integrins can bind multiple ligands.
RT-qPCR analysis was performed for 9 selected α and 5
selected β subunits. The integrin subunits following the
FN1 expression profile (ITGA2B, ITGA3, ITGA5, ITGA8,
ITGAV and ITGB3) and the ITGB1 subunit expressed in all
the tested developmental stages, were considered as
potential receptors for the new embryonic FN1 splice iso-
form. ITGAD and ITGB7 were only expressed at the
hatched blastocyst stage, making them good candidate
receptors for FN1 isoform 2. Furthermore, remarkable dif-
ferences in integrin RNA expression were found between
in vivo and in vitro produced blastocysts. The embryonic
origin might not only influence the FN1 expression but
also the integrin expression, or ligand and receptor might
regulate each others expression.
The double immunofluorescent stainings on in vitro pro-
duced bovine blastocysts found ITGA3 mainly located in
the TE cells, whereas ITGA5 and ITGAV were stronger
expressed in the ICM. Although the integrins were
expressed in close proximity to FN1, there was no full co-
localisation between FN1 and one of 3 the receptors.
Either, none of the tested integrins was the unique FN1
receptor, each integrin receptor can bind to other ligands
besides FN1, or the FN1-ESV isoform can interact with
more than one integrin receptor by the dual RGD
sequences. One should keep in mind that analogous to
the differences observed for RNA expression, differences
in protein expression can exist between in vitro and in vivo
golden standard embryos. ITGA2B and ITGA8 were not
tested in this study due to the lack of suitable, specific
antibodies. Our approach using RNA expression pattern
analysis and double immunofluorescent stainings
excluded some integrins as candidate binding partners for
the embryo specific FN1 isoform, but we were not able to
identify one specific FN1 receptor in bovine blastocysts.
The application of other molecular techniques such as the
yeast two hybrid method [51] or the MAPPIT strategy [52]
will be necessary for further analysis of the FN1-integrin
interaction in bovine blastocysts in order to find out more
about the function of FN1 during early blastocyst forma-
tion.
Conclusion
In this study, we have established a reliable assay for
mRNA quantification of different FN1 splice isoforms.
The assay was used for FN1 expression analysis in bovine
oocytes, embryos, cumulus cells and adult tissues and as
such we have identified 2 novel FN1 isoforms, specifically
expressed in early embryos and cumulus cells, respec-
tively. The existence of the FN1-ESV transcript variant
strengthens our hypothesis that FN1 may exert a specific
function during blastocyst formation.
Expression analysis of integrins, the main family of FN1
receptors, during bovine preimplantation embryo devel-
opment was a first step towards unravelling the FN1 func-
tion during blastocyst formation. RT-PCR identified
candidate binding partners for the FN1-ESV isoform, but
detailed identification of its receptor needs further inves-
tigation to test our hypothesis that the embryonic FN1
matrix has the adhesive property to link cells together and
provides a substrate for cell layer migration.Page 11 of 16
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Sample collection
In vivo embryo production
In vivo embryos were produced according to the protocol
described in Goossens et al. [33]. This protocol has been
approved by the local ethical committee and was done
after superovulation and artificial insemination of 4 Hol-
stein cows for the collection of 2-cell and 8-cell embryos
and 2 Holstein heifers for the collection of blastocysts.
The same bull was used for in vivo and in vitro insemina-
tion. Four 2-cell and four 8-cell embryos were recovered
from the reproductive tract of slaughtered donor animals,
on 36 hours respectively 84 hours after artificial insemina-
tion (AI). The embryos were recovered from the oviducts
by flushing with warm PBS supplemented with 2% FCS.
Four blastocysts were recovered by nonsurgical uterine
flushing with 0.5 l of PBS on day 7 after AI.
In vitro embryo production
Bovine embryos were produced by routine in vitro meth-
ods as described by Vandaele et al. [53]. Briefly, bovine
cumulus-oocyte complexes (COCs) were aspirated from
ovaries collected at a local slaughterhouse. Immature
COCs were recovered from follicular fluid, washed two
times in HEPES-TALP and matured for 20 to 24 hrs in
groups of 100 in 500 μl modified bicarbonate buffered
TCM199 (Gibco BRL, Belgium) supplemented with 20%
heat-inactivated FCS (Sigma-Aldrich, Belgium) for 20–24
hrs at 38.5°C in a humidified 5% CO2 incubator.
Frozen-thawed bovine sperm was separated over a Percoll
gradient (45% and 90%; Pharmacia, Sweden), washed
and diluted in IVF-TALP consisting of bicarbonate buff-
ered Tyrode solution, supplemented with BSA (6 mg/ml)
and heparin (25 μg/ml) to a final sperm concentration of
1 × 106spermatozoa/ml. The matured COCs were washed
in 500 μl IVF-TALP and incubated with sperm. After 20 hrs
co-incubation, the presumed zygotes were vortexed to
remove excess sperm and cumulus cells. The complete
removal of the cumulus cells was checked by microscopy.
The zygotes were washed and placed in groups of 25 in 50
μl droplets of synthetic oviduct fluid supplemented with
5% foetal calf serum and cultured up to the desired stages
(2-cell, 8-cell, morula, blastocyst and hatched blastocyst)
at 38.5°C in 5% CO2, 5% O2 and 90% N2.
Cumulus cell culture
Matured oocytes were vortexed in 500 μl IVF-TALP to
remove the surrounding cumulus cells. The oocytes were
removed and the remaining medium containing the
cumulus cells was centrifuged for 10 min at 750 × g. After
centrifugation, the pellet of cumulus cells was suspended
in cumulus medium containing TCM-199 (Gibco BRL,
Belgium), Gentamycin and 10% FCS (Sigma-Aldrich, Bel-
gium). The cumulus cells were cultured for 7 days in 4-
well plates, preincubated with 300 μl of FCS to enhance
cell attachment, in a humidified 5% CO2 incubator. The
cumulus medium was renewed every 2 to 3 days with
freshly prepared cumulus medium.
After 7 days, the monolayer of cumulus cells was scraped
from the bottom of the 4-well plate, collected in a micro-
centrifugation tube, washed 3 times with PBS and imme-
diately frozen at -80°C until RNA extraction.
Collection of bovine tissues
In a commercial slaughterhouse, different bovine tissue
samples (kidney, liver, lung, udder, placenta, spleen, mus-
cle, heart, uterus, skin and ovary) were carefully collected
from 4 different Holstein cows. The samples were imme-
diately submerged in RNAlater (Sigma-Aldrich, Belgium)
for RNA preservation, after which they were crushed to
powder with liquid nitrogen, subdivided per 80–100 mg
and stored at -80°C, until total RNA extraction.
RNA extraction and cDNA synthesis
Total RNA was isolated from single oocytes (6×), single
embryos (6× 2-cell, 6× 8-cell, 6× morulae, 6× blastocysts
and 4× hatched blastocysts for the in vitro embryos; 4× 2-
cell, 4× 8-cell and 4× blastocysts for the in vivo embryos)
and the pellets of cumulus cells (4×) using the PicoPure
RNA Isolation Kit (Arcturus, CA) according to the manu-
facturer's instructions. An in-solution DNase digestion
was carried out to remove any contaminating DNA by
treating the total RNA with 2 units of RQ1 DNase
(Promega, The Netherlands) during 30 min, followed by
a spin-column purification (Microcon YM-100, Millipore,
Belgium).
Total RNA was extracted from the bovine tissue samples
(4 samples/tissue) using the Aurum Total RNA Fatty and
Fibrous Tissue Kit (Bio-Rad, Belgium) according to the
products manual. An on-column DNase I digest was per-
formed during the RNA extraction protocol.
A minus RT control was performed with primers for
GAPD to check the removal of the genomic DNA and
First-strand cDNA was synthesized from the total amount
of RNA using the iScript cDNA synthesis kit (Bio-Rad, Bel-
gium) following the manufacturer's instructions. The
iScript Reverse Transcriptase is a modified MMLV-derived
reverse transcriptase and the iScript Reaction Mix contains
both oligo(dT) and random primers. After the RT reaction
and RT control with primers for GAPD, the cDNA was 2.5
times diluted in 10 mM Tris HCl pH 8.0.
Primer design
All the primers were designed using the Primer 3 software
[54] and are based on the sequences available in NCBI
GenBank [38] (Table 1).Page 12 of 16
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were designed. Primer pairs 1–3 (Figure 1; Table 1) are
surrounding the alternative spliced regions and make the
distinction between the presence and the absence of the
alternatively spliced regions possible. These primers were
also used for the generation of the specific standards.
Primer pairs 4–6 (Figure 1; Table 1) are used for specific
amplification of the full-length splice regions (EIIIB+,
EIIIA+ and IIICS+) with one of the primers located in the
specific spliced region. Primer pairs 7–9 (Figure 1; Table
1) are boundary spanning primers used for specific ampli-
fication of the EIIIB-, EIIIA- and IIICS- regions.
Additionally, primers were designed for the RNA expres-
sion analysis of 9 different integrin α subunits and 5 dif-
ferent integrin β subunits (Table 1), known from literature
to be candidate receptors for FN1.
All the PCR amplicons were sequenced for verification.
Reverse Transcription qPCR
Generation of splice variant specific qPCR standards
The FN1 regions spanning EIIIB, EIIIA and IIICS were
amplified with primer pairs 1 to 3 respectively, using
pooled cDNA from bovine oocytes, embryos, cumulus
cells and adult tissues. The generated PCR products (Table
1) were cloned into a pCR 2.1 vector (Invitrogen, Bel-
gium) and transformed into competent DH5α E. coli cells
(Invitrogen, Belgium). Clones were randomly picked and,
after sequencing of the inserts, used for generation of
gene-specific qPCR standards.
The cDNA fragment of each isoform was amplified by
using 20 ng of the specific plasmids as the template for a
PCR reaction. PCR fragments were run on a 2% agarose
gel, excised and eluted using the Geneclean II kit (Q-Bio
gene – MP Biomedicals, Belgium). PCR fragments were
quantified using the PicoGreen Kit (Molecular Probes –
Invitrogen, Belgium) on a NanoDrop 3300 Fluorospec-
trometer (Isogen Life Science B. V., Belgium) and the
molar concentration of each PCR product was calculated
on the basis of the mass concentration and the length in
base pairs of each fragment as described in Vanden-
broucke et al. [36]. Standard curves are generated by 10-
fold serial dilutions of specific PCR products as validated
by Vandenbroucke et al. [36].
Quantification of alternative transcripts using boundary spanning 
primers
Primer pairs designed for specific detection of each splice
variant (Table 1, primers 4–9) were used in combination
with SYBR Green I (Platinum SYBR Green qPCR Super-
Mix-UDG; Invitrogen, Belgium).
First, the specificity of the primers was tested by amplify-
ing each splice variant in the presence of excess on the
alternative splice form. In concrete terms this means that
for each alternatively spliced region, a dilution series of
the PCR product of the short transcript was mixed with
excess of the PCR product of the full-length transcript or
with equal amounts of water in a second and similar series
of dilution. The same was done for each of the full-length
transcripts.
Each qPCR reaction contained 1× SYBR Green I PCR Mix
(Platinum SYBR Green qPCR SuperMix-UDG; Invitrogen,
Belgium), 200 nM of each specific primer and 2.5 μl of
sample. After a 2 min UDG incubation step at 50°C and
an initial denaturation step at 95°C for 3 min to activate
the Taq DNA polymerase, the PCR programme consisted
of 45 cycles of denaturation at 95°C for 20 sec and a com-
bined primer annealing/extension at the specific and opti-
mised annealing temperature (Table 1) for 40 sec during
which fluorescence was measured. A melt curve was pro-
duced to confirm a single gene-specific peak and to detect
primer/dimer formation by heating the samples from 70
to 95°C in 0.5°C increments with a dwell time at each
temperature of 10 sec while continuously monitoring the
fluorescence. PCR efficiencies were calculated using a rel-
ative standard curve derived from each specific PCR prod-
uct (a ten-fold dilution series with five measuring points).
For each reaction two technical replicates were run,
whereby a no-template control was included.
The geometric mean of three validated reference genes
(YWHAZ, GAPD and SDHA) [55] was used to calculate an
accurate normalisation factor for normalisation of the
total FN1 RNA expression level. The mean quantity of
each transcript (raw data) was divided by the respective
normalisation factor to obtain a normalised value for
each transcript. The relative proportion of each splice var-
iant was determined by interpolating the CT values of the
unknown samples to the corresponding standard curve
and subsequently used for the calculation of the composi-
tion of the total FN1 expression.
Expression analysis of integrins in bovine preimplantation embryos
In a first screening experiment, the expression profiles of
the 14 selected integrin subunits (Table 2) were deter-
mined in different stages of embryonic development
using RT-qPCR as previously described. In a second exper-
iment the integrin expression was compared between in
vivo and in vitro produced embryos (2-cell, 8-cell and blas-
tocysts), also by RT-qPCR.
Statistical analysis
The gene expression levels were analysed by calculating
95% confidence intervals after logarithmic transforma-Page 13 of 16
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cant differences at the 0.05 level.
Statistical tests were performed using the GraphPad Instat
program. An ANOVA test was performed to compare the
overall FN1 expression between oocytes, embryos, cumu-
lus cells and adult tissue samples. A t-test was used to
compare the relative FN1 splice variant expression in each
sample type. An (unpaired) t-test was used for compari-
son of the FN1 splice variant and the integrin expression
between in vivo and in vitro produced embryos. P-values <
0.05 were considered statistically significant.
Immunofluorescent stainings
Double immunofluorescent stainings were performed for
FN1 in combination with a candidate FN1 receptor
(ITGA3, ITGA5 or ITGAV). A primary mouse monoclonal
antibody (AB6328 – Abcam, UK) against FN1 was used in
combination with a secondary goat-anti-mouse antibody
labelled with Cy5 (Chemicon – Millipore, Belgium). The
primary rabbit integrin antibodies (ITGA5 (C2405-02D):
USBiological – Immunosource, Belgium; ITGA3
(AB1920) and ITGAV (AB1930): Chemicon – Millipore,
Belgium), guaranteed to have no-cross reactivity with
other integrins were used in combination with a second-
ary goat-anti-rabbit antibody labeled with FITC (Molecu-
lar Probes, The Netherlands).
In vitro blastocysts were selected from the culture media at
day 7 p.i., washed 3 times in PBS and fixed with ice cold
acetone for 10 min at 4°C. After washing in polyvinyl pyr-
rolidone (PVP; 1 mg PVP/ml PBS), non-specific binding
sites were blocked by incubating the embryos with 10%
goat serum in PVP for 30 min. After 3 washes in PVP the
embryos were incubated with the mouse primary, mono-
clonal antibody against FN1 (1/100) for 2 hours at 37°C,
washed again 3 times in PVP and then incubated over-
night at 4°C with the specific rabbit antibody against one
of the 3 selected integrins (1/100). Afterwards, the
embryos were washed 3 times with PVP, incubated with
the secondary goat-anti-mouse antibody labelled with
Cy5 for 1 hour at 37°C (1/100), washed again with PVP
and incubated with the secondary goat-anti-rabbit anti-
body labelled with FITC (1/100).
The nuclei were stained with Hoechst 33258 (Molecular
Probes, Belgium) for 10 min at room temperature and
immediately mounted in a droplet of glycerol with (25
mg/ml) 1,4-diazabicyclo (2.2.2) octane (DABCO; Acros,
Belgium) on slides with vaseline bridges.
Negative controls (by replacing the primary antibody with
goat serum), double negative controls (only Hoechst
staining) and controls for cross reactivity of the antibodies
were performed simultaneously to check for non-specific
binding and for auto-fluorescence. A monolayer of cul-
tured cumulus cells was used as a positive control.
Samples were evaluated using a Leica DM/RBE fluores-
cence microscope (Leica Microsystems Belgium) and a
Nikon C1 confocal laser scanning module attached to a
motorized Nikon TE2000-E inverted microscope (Nikon
Benelux, Belgium) equipped with a Plan Apo 40× 0.95 NA
air objective and suitable optical elements to acquire dif-
ferential interference contrast (DIC) transmission images.
An argon 488 nm laser, a Helium-neon 633 nm laser, and
a 351 nm UV-laser were used for the excitation of FITC,
Cy5, and Hoechst, respectively.
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